Totally understandable, your thoughts, but the wild card here is coronavirus. If leronlimab helps people fight it once they have it, well, the world will need it and EVERYONE will know of CytoDyn. At that point, leronlimab becomes undeniable, because we already (allegedly) have other countries interested in leronlimab for cancer as well.

Hang in there...same circus, same clowns...but maybe this time the show will be different. I think it will be!